Enliven Therapeutics ELVN Delivers Q1 2026 Beat EPS 038 vs 047 Expected Valaris VAL Q1 2026 Results Disappoint What Investors Should Know Markets Rally Broadly as Tech Leads Strong Session UK Government Pledges 120 Million to Support Ceramics Industry MetaMask Expands Tokenized Stock Trading US Users Excluded SoftBank Group Surges 20 as Nvidia Earnings Fuel Renewed AI Optimism